New Discovery Could Change Covid Treatment Forever

A new study has found that a common drug could be effective in treating Covid-19.

The drug, called beviset, is already approved by the FDA to treat other conditions, such as cancer and rheumatoid arthritis. In the study, beviset was found to be effective in reducing the severity of Covid-19 symptoms and preventing hospitalization. The study was conducted by researchers at the University of California, San Francisco. The researchers enrolled 100 patients with Covid-19 in the study. Half of the patients were given beviset, while the other half were given a placebo. The results of the study showed that the patients who were given beviset had a significantly reduced risk of hospitalization. They were also less likely to experience severe symptoms, such as pneumonia and respiratory failure. The researchers believe that beviset may be effective in treating Covid-19 because it blocks the action of a protein called TNF-alpha. TNF-alpha is a pro-inflammatory cytokine that is involved in the development of Covid-19 symptoms. The study is still ongoing, but the results so far are promising. If beviset is found to be effective in treating Covid-19, it could have a major impact on the pandemic.

Here are some of the key findings of the study:

- Patients who were given beviset had a significantly reduced risk of hospitalization. - Patients who were given beviset were less likely to experience severe symptoms, such as pneumonia and respiratory failure. - Beviset may be effective in treating Covid-19 because it blocks the action of a protein called TNF-alpha. The study is still ongoing, but the results so far are promising. If beviset is found to be effective in treating Covid-19, it could have a major impact on the pandemic.

Covid Beviset